Mr. Steve Chriscoe, Vice President, Project Management – United States has worked in clinical research since 1995 and has worked for WCT since February 2021.
He began his career as a CRA before moving into a Clinical Research Scientist role at a large pharmaceutical company, where he continued to monitor clinical trials in addition to doing study management and writing. Mr. Chriscoe first became a Project Manager over 20 years ago, and since that time has held a variety of roles in project management, clinical operations and development. He has experience working in larger pharma, small biotech, as well as the CRO industry.
Mr. Chriscoe has served in an oversight role or as Project Manager for a variety of programs in Oncology:
- Phase I – IV, with a focus on early phase studies including FIH and dose escalation/expansion
- Immuno-oncology as well as CAR-T therapies
- Solid tumor types include breast, cervical, prostate, bladder, pancreas, head & neck, liver & lung
- Liquid tumor types include NHL, AML, and CLL
Mr. Chriscoe also has project management & clinical development experience in AAV-based gene therapy for rare diseases such as Pompe disease, Huntington’s disease, MMA, muscular dystrophy and Angelman syndrome. This includes experience from pre-clinical through registrational studies.
Mr. Chriscoe holds a Bachelor’s degree in Physical Education from the University of North Carolina-Wilmington, and a Master’s degree in Exercise Physiology from the University of North Carolina.
Clinical research professional with 25 years of experience in clinical and medical affairs, most recently as Director of Clinical Affairs and Associate Director of Medical Affairs for a global medical device manufacturer focusing on endovascular and surgical repair of aortic disease.
Vicky Davies is Senior Global Marketing Director for Performance, Active & Medical Nutrition at FrieslandCampina Ingredients. She trained as a physiologist and nutritionist, and has a PhD in nutritional biochemistry. She has been working in health and nutrition for 20 years, holding posts in academia and clinical nutrition research, as well as leadership roles in communications and marketing in leading multi-national companies, including Danone and Philips.
At FrieslandCampina Ingredients, Vicky is responsible for the global marketing and innovation strategy in Performance, Active and Medical nutrition. With her team, she strives to bring locally relevant, superior and beneficial nutrition and health related solutions to customers and consumers around the globe.
Vicky is passionate about her work, which enables her to bring together her love of nutrition and business, to have a positive and holistic impact on people’s health throughout their lives.
Carol Hamilton serves as Chief Commercial Officer for Provenir AI, a global leader in data and AI-powered risk decisioning software. Carol is responsible for leading and extending Provenir AI solutions including credit, fraud and identity.
Hamilton brings rich experience in developing fraud, compliance and security solutions for the financial services industry. Prior to joining Provenir, Hamilton held senior leadership roles at GBG, SAS and BAE Systems leading regional teams responsible for creating long-term strategy, driving growth, and seeking new areas for expansion.
Carol earned a master’s degree in Mathematics at University of Bath and completed the Executive Leadership Program at Saïd Business School, University of Oxford.
I am a true entrepreneur and your classic visionary in every sense. A musician from the age of 5, at the tender age of 18 I signed my first record deal and became a professional musician. My band Baddax had multiple releases in the 1990’s with minor success, and toured throughout the country. I then spent the next few years as a professional screenwriter with 2 scripts optioned, as well as ghostwriting for other scripts. I have owned multiple businesses throughout my career, ranging from construction to sales/marketing, and of course, the entertainment industry. I made the switch to vaping in 2007 and stared perfecting the craft of making the ultimate eliquids. I founded Innevape Eliquids in 2012 with the singular mission of changing people’s lives for the better, the way vaping has changed mine.
Catharine Dockery is the founder and general partner at Vice Ventures. She entered venture capital after working in retail M&A on Walmart’s digitally native vertical brands team and has prior experience in equity trading and high-yield credit research. Through her work with the fund, she’s been recognized in various media, including as a headline member of Forbes’ 30 Under 30 for 2020. Her passion for top-quality brands and pockets of market opportunity led her to start Vice Ventures in 2018 with Fund I’s first close in 2019. Dockery graduated from New York University’s Gallatin School of Independent Study, where she concentrated on a combination of neuroscience and finance.
Elena Meskhi is the owner of an accounting and tax advisory practice that has been operating for over a decade. She’s also a book author, business coach, NLP masters practitioner, and public speaker who is passionate about allowing business owners to experience financial freedom.
